Gleason Pattern 5 prostate cancer: further stratification of patients with high-risk disease and implications for future randomized trials.
about
Evaluation of protein biomarkers of prostate cancer aggressivenessAdjuvant medical therapy for prostate cancer.Pre-treatment risk stratification of prostate cancer patients: A critical review.Evaluation of biochemical recurrence in patients with high-risk prostate cancer treated with radical prostatectomy and radiotherapy plus androgen deprivation therapy.Treatment strategies for high-risk locally advanced prostate cancer.Can we improve the definition of high-risk, hormone naïve, non-metastatic prostate cancer?Characteristics of modern Gleason 9/10 prostate adenocarcinoma: a single tertiary centre experience within the Republic of Ireland.Heterogeneity in high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation therapyThe very-high-risk prostate cancer: a contemporary update.Gleason grading: past, present and future.Oncological outcomes in an Australian cohort according to the new prostate cancer grading groupings.Risk of Death from Prostate Cancer with and without Definitive Local Therapy when Gleason Pattern 5 is Present: A Surveillance, Epidemiology, and End Results Analysis.Impact of Gleason Pattern 5 on outcomes of patients with prostate cancer and iodine-125 prostate brachytherapy.Gleason 5+4 has worse oncological and pathological outcomes compared with Gleason 4+5: significance of Gleason 5 pattern.Independent surgical validation of the new prostate cancer grade-grouping system.Gleason pattern 5 is the strongest pathologic predictor of recurrence, metastasis, and prostate cancer-specific death in patients receiving salvage radiation therapy following radical prostatectomy.Impact of Gleason pattern 5 including tertiary pattern 5 on outcomes of salvage treatment for biochemical recurrence in pT2-3N0M0 prostate cancer.Impact of tertiary Gleason pattern 5 on prostate cancer aggressiveness: Lessons from a contemporary single institution radical prostatectomy series.
P2860
Q21261257-78F1BB86-1968-4DD4-B302-0AC23EDCC3DBQ33758771-40CF3CD6-5C90-435B-AE37-C5ED40FA89CCQ34268868-0A0803E0-5A63-4344-86A5-658B095322F1Q37485340-02F24307-817F-430A-AE73-B7D714FE827CQ37671592-08734415-636D-4AA9-ACBC-CB128EF66300Q38151298-A6196E53-DA27-4798-A2CF-60DB3953D8BBQ38152998-3C17723A-CA15-4602-9DB4-40C6B6B786B1Q38648500-CAD7BF58-124B-455C-BDB6-1076A84244A8Q38952181-413A4B1B-9E44-4A91-B9F5-21E45458356FQ39668527-5FAD2B7B-5033-499A-A60B-FC5E87DC207AQ40087220-2C62D847-C027-4DF9-9A73-2875E67CA540Q41497517-06F4EE27-47BC-44FD-BB20-15C6D8F96AB8Q42353593-50DF116A-A98B-4785-9E63-BE5BDC3BB513Q44745051-F72B2DF2-46A1-4F95-B7C0-C869E65C2E92Q48297609-5D00F6B6-0E14-4B53-AE01-DE144BE8C61BQ50861919-2494202C-C52F-4A4E-BAE6-9A2F4FD5A1D0Q53118153-22E53EA5-FA5B-49C6-9442-C6946FF9FABEQ53649430-833D74E0-F49B-4498-9393-0B9F5F81144D
P2860
Gleason Pattern 5 prostate cancer: further stratification of patients with high-risk disease and implications for future randomized trials.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Gleason Pattern 5 prostate can ...... for future randomized trials.
@en
type
label
Gleason Pattern 5 prostate can ...... for future randomized trials.
@en
prefLabel
Gleason Pattern 5 prostate can ...... for future randomized trials.
@en
P2093
P1476
Gleason Pattern 5 prostate can ...... for future randomized trials.
@en
P2093
Akash Nanda
Andrew A Renshaw
Anthony V D'Amico
Ming-Hui Chen
P304
P356
10.1016/J.IJROBP.2008.10.027
P407
P577
2009-01-07T00:00:00Z